Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Thermo Fisher Opens New Biologics Mfg. Site in Switzerland | Contract Pharma

What are you searching for?

Sign in
Breaking News

Thermo Fisher Opens New Biologics Mfg. Site in Switzerland

The 1.5 million sq.-ft. facility will leverage highly flexible bioproduction technologies, including single-use and stainless steel with up to 12,500L capacity.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific Inc. has assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland as part of its previously announced strategic partnership with CSL Ltd. The Lengnau site will become part of Thermo Fisher’s global biologics manufacturing network, and approximately 200 employees will join Thermo Fisher.
 
The Lengnau site is a 1.5 million sq.-ft. facility that will leverage highly flexible bioproduction technologies, including both single-use and stainless steel with up to 12,500L bioreactor capacity. This will provide a pathway from development to large-scale production as manufacturing needs evolve. 
 
Following completion of site construction in 2022, Thermo Fisher will initially support manufacturing of CSL’s next-gen recombinant factor IX product Idelvion for hemophilia B. Thermo plans to expand the use of the site to include additional biopharma customers.
 
The Lengnau site is an important expansion of Thermo Fisher’s biologics manufacturing network that includes Princeton, NJ and St. Louis, MO, USA; Groningen, NL; Brisbane, AU; and Hangzhou, China.
 
“We are excited to add the new Lengnau site to our global biologics manufacturing network and we are thrilled to welcome more than 200 new colleagues to Thermo Fisher,” said Michel Lagarde, executive vice president of Thermo Fisher Scientific. “Through our partnership with CSL, this site further strengthens our unique customer value proposition to leverage our scale and depth of capabilities for pharma and biotech customers. With the addition of new high-volume stainless-steel capabilities in Lengnau, we are enabling our customers to start their projects with us and stay with us as their manufacturing requirements grow.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics